Leveraging and manufacturing in vitro multicellular spheroid-based tumor cell model as a preclinical tool for translating dysregulated tumor metabolism into clinical targets and biomarkers
Abstract The grand challenge now and in the near future for the pharmaceutical industry is how to efficiently improve R&D productivity. Currently, the approval rate of the entire clinical drug development process is extremely low, and the high attrition in the phase I clinical trial is up to 95%...
Main Authors: | Tong Wang, Lin Wang, Guan Wang, Yingping Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-07-01
|
Series: | Bioresources and Bioprocessing |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40643-020-00325-7 |
Similar Items
-
Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids
by: Stephen Riffle, et al.
Published: (2017-08-01) -
Natural and Synthetic Biomaterials for Engineering Multicellular Tumor Spheroids
by: Advika Kamatar, et al.
Published: (2020-10-01) -
Applications and Advances of Multicellular Tumor Spheroids: Challenges in Their Development and Analysis
by: Achilleas G. Mitrakas, et al.
Published: (2023-04-01) -
A Novel 3D Culture Scaffold to Shorten Development Time for Multicellular Tumor Spheroids
by: Cian-Ru Yang, et al.
Published: (2022-11-01) -
Ultrasound-Based Scaffold-Free Core-Shell Multicellular Tumor Spheroid Formation
by: Karl Olofsson, et al.
Published: (2021-03-01)